Avestar Capital, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1704404 New York, NY

Position in REGN

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$419,642

-$89,527 QoQ

Shares Held

673

+2.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#852

of 1,322 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Avestar Capital, LLC holds $2,161,613 across 4 Biotechnology names. REGN ranks #2 (19.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,898	$1,439,523
2	REGN	Regeneron Pharmaceuticals, Inc. This page	673	$419,642
3	CRDF	Cardiff Oncology, Inc.	136,145	$176,988
4	AGEN	Agenus Inc	41,000	$125,460

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$419,642	673	+2.1%	Shares	Sole	2026-07-29
2026-03-31	$509,169	659	+3.8%	Shares	Sole	2026-05-13
2025-12-31	$490,137	635	-31.7%	Shares	Sole	2026-02-10
2025-09-30	$522,911	930	+82.4%	Shares	Sole	2025-11-07
2025-06-30	$267,750	510	-24.3%	Shares	Sole	2025-08-13
2025-03-31	$427,471	674	-14.4%	Shares	Sole	2025-05-14
2024-12-31	$560,603	787	+8.9%	Shares	Sole	2025-01-29
2024-09-30	$760,046	723	+7.7%	Shares	Sole	2024-11-13
2024-06-30	$705,241	671	-2.5%	Shares	Sole	2024-08-08
2024-03-31	$662,193	688	+88.5%	Shares	Sole	2024-05-10
2023-12-31	$320,575	365	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.